LYFE Capital

Singapore · Invests in Singapore · Website

Check size

Series B Growth Healthcare & Biotech Education Robotics Hardware & Deviceshealthcaremedical devicesbiotechpharmacdmomedtechdiagnosticssurgical robotics

Thesis

Healthcare-only investment platform (~$2B AUM) backing companies critical to the global healthcare supply chain, specialized product platforms and next-generation R&D services, and helping them expand revenue between Asia and the U.S. Strategy skews late-stage growth and control/buyout (including public tender offers) rather than early venture, but the site runs an explicit founder inbound path (information@lyfecapital.com).

Profile drafted from public signals. Our research team reviews every firm.